| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | NEUTRAL | BUY | NEUTRAL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 18.73▼ | 18.75▼ | 18.76▼ | 18.56▲ | 18.82▼ |
| MA10 | 18.72▼ | 18.77▼ | 18.73▼ | 18.54▲ | 19.18▼ |
| MA20 | 18.74▼ | 18.74▼ | 18.65▲ | 18.69▲ | 19.49▼ |
| MA50 | 18.75▼ | 18.64▲ | 18.57▲ | 19.19▼ | 18.75▼ |
| MA100 | 18.68▲ | 18.58▲ | 18.63▲ | 19.47▼ | 16.65▲ |
| MA200 | 18.60▲ | 18.66▲ | 18.91▼ | 19.21▼ | 14.18▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.001▼ | -0.009▼ | 0.004▲ | 0.036▲ | -0.200▼ |
| RSI | 45.694▼ | 51.155▲ | 54.112▲ | 46.683▼ | 46.805▼ |
| STOCH | 57.308 | 56.471 | 65.963 | 27.197 | 11.175▼ |
| WILL %R | -53.846 | -46.429 | -39.394 | -69.960 | -84.426▼ |
| CCI | -47.887 | -44.676 | -40.811 | 45.921 | -130.676▼ |
|
Wednesday, October 21, 2026 01:13 AM
Merck secures expanded EU approval for KEYTRUDA plus Padcev in muscle-invasive bladder cancer after Phase 3 data showed improved survival outcomes.
|
|
Tuesday, October 20, 2026 09:34 AM
A Growing Franchise With an Expiration Date Merck & Co., Inc. (NYSE:MRK) is trying to extend its oncology leadership before competition threatens its largest earnings engine. Keytruda and Keytruda ...
|
|
Monday, October 19, 2026 08:24 PM
Merck & Co., Inc. (NYSE:MRK) stands tall in the pharmaceutical world, thanks to its rich portfolio of patented medicines, strong ties with healthcare providers, global reach, and decades of investment ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 23/10/26 | 18.72 | 18.96 | 18.51 | 18.72 | 81,999 |
| 22/10/26 | 18.40 | 18.85 | 18.40 | 18.75 | 89,678 |
| 21/10/26 | 18.63 | 18.705 | 18.34 | 18.40 | 58,000 |
| 20/10/26 | 18.48 | 18.865 | 18.45 | 18.48 | 77,967 |
| 19/10/26 | 18.50 | 18.665 | 18.42 | 18.44 | 41,757 |
| 16/10/26 | 18.46 | 18.80 | 18.46 | 18.51 | 67,817 |
| 15/10/26 | 18.55 | 18.75 | 18.34 | 18.41 | 60,614 |
| 14/10/26 | 18.37 | 18.70 | 18.34 | 18.44 | 74,910 |
| 13/10/26 | 18.77 | 18.99 | 18.45 | 18.58 | 85,640 |
| 12/10/26 | 18.61 | 18.90 | 18.61 | 18.71 | 50,754 |
|
|
||||
|
|
||||
|
|